Trials without tribulations: Minimizing the burden of pragmatic research on healthcare systems.

Pragmatic clinical trials are increasingly common because they have the potential to yield findings that are directly translatable to real-world healthcare settings. Pragmatic clinical trials need to integrate research into clinical workflow without placing an undue burden on the delivery system. This requires a research partnership between investigators and healthcare system representatives. This paper, organized as a series of case studies drawn from our experience in the NIH Health Care Systems Research Collaboratory, presents guidance from informational interviews of physician-scientists, health services researchers, and delivery system leaders who recently launched pragmatic clinical trials.

[1]  Joseph V. Selby,et al.  PCORI at 3 years--progress, lessons, and plans. , 2014, The New England journal of medicine.

[2]  J. Lellouch,et al.  Explanatory and pragmatic attitudes in therapeutical trials. , 1967, Journal of chronic diseases.

[3]  John R. Yates,et al.  Sirt1 mediates neuroprotection from mutant huntingtin by activation of TORC1 and CREB transcriptional pathway , 2011, Nature Medicine.

[4]  Chris Tachibana,et al.  A guide to research partnerships for pragmatic clinical trials , 2014, BMJ : British Medical Journal.

[5]  Russell E. Glasgow,et al.  What Does It Mean to Be Pragmatic? Pragmatic Methods, Measures, and Models to Facilitate Research Translation , 2013, Health education & behavior : the official publication of the Society for Public Health Education.